leadf
logo-loader
CSE:AGN OTCQB:AGNPF

Algernon Pharmaceuticals Inc.

Receive alerts
Market:
CSE
Market Cap:
$51.17 m
Price
0.37 CAD
Change
5.80%
52 weeks high
0.58
52 weeks low
0.09

In brief

Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

Snapshot

Repurposed compounds have a much lower risk of failing in human trials on safety issues, the company has said